SCHEMBL844996

SCHEMBL844996

CC(=O)c1ccccc1C(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3ccccc3C(C)=O)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
NPC1 O15118 1/20 0.49
MAPK1 P28482 2/20 0.48
GAA P10253 2/20 0.48
ALDH1A1 P00352 3/20 0.48
HTT P42858 1/20 0.48
LMNA P02545 1/20 0.48
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
PABPC1 P11940 1/20 0.46
TRPV1 Q8NER1 1/20 0.46
EP300 Q09472 1/20 0.45
CREBBP Q92793 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845929 0.93 GAA (0.48) CYP2C9CYP2C19NPC1MAPK1GAA
SCHEMBL845008 0.90 ALDH1A1 (0.54) CYP2C9CYP2C19MAPK1ALDH1A1HTT
SCHEMBL845285 0.88 GAA (0.48) CYP2C9CYP2C19MAPK1GAAALDH1A1
SCHEMBL845007 0.87 PABPC1 (0.49) CYP2C9CYP2C19MAPK1GAAALDH1A1
SCHEMBL845131 0.87 PABPC1 (0.49) CYP2C9CYP2C19MAPK1GAAALDH1A1
SCHEMBL845350 0.87 MAPK1 (0.49) CYP2C9CYP2C19MAPK1GAAALDH1A1
SCHEMBL845443 0.87 CYP2C9 (0.47) CYP2C9CYP2C19MAPK1ALDH1A1HTT
SCHEMBL845257 0.87 TRPV1 (0.48) CYP2C9CYP2C19MAPK1ALDH1A1HTT
SCHEMBL845284 0.86 MAPK1 (0.58) CYP2C9CYP2C19MAPK1GAAALDH1A1
SCHEMBL845016 0.86 CYP2C9 (0.47) CYP2C9CYP2C19MAPK1ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed